Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 8/20 | 0.64 |
| ▸ | YES1 | P07947 | 6/20 | 0.64 |
| ▸ | FGR | P09769 | 6/20 | 0.64 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.53 |
| ▸ | FYN | P06241 | 6/20 | 0.51 |
| ▸ | LYN | P07948 | 3/20 | 0.51 |
| ▸ | ABL1 | P00519 | 5/20 | 0.47 |
| ▸ | RET | P07949 | 4/20 | 0.47 |
| ▸ | LCK | P06239 | 3/20 | 0.47 |
| ▸ | FRK | P42685 | 2/20 | 0.47 |
| ▸ | DYRK3 | O43781 | 2/20 | 0.45 |
| ▸ | CDK1 | P06493 | 2/20 | 0.45 |
| ▸ | ROS1 | P08922 | 2/20 | 0.45 |
| ▸ | RPS6KB1 | P23443 | 2/20 | 0.45 |
| ▸ | CDK2 | P24941 | 2/20 | 0.45 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.45 |
| ▸ | CSNK1D | P48730 | 2/20 | 0.45 |
| ▸ | CLK2 | P49760 | 2/20 | 0.45 |
| ▸ | IRAK1 | P51617 | 2/20 | 0.45 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4825100 | 0.92 | SRC (0.56) | SRCYES1FGRPIK3CDFYN | |
| SCHEMBL25030582 | 0.83 | SRC (0.49) | SRCYES1FGRPIK3CDFYN | |
| SCHEMBL18258364 | 0.83 | ABL1 (0.51) | SRCYES1FGRPIK3CDFYN | |
| SCHEMBL18250080 | 0.83 | SRC (0.68) | SRCYES1FGRPIK3CDFYN | |
| SCHEMBL26148542 | 0.82 | SRC (0.58) | SRCYES1FGRPIK3CDFYN | |
| SCHEMBL18258360 | 0.81 | SRC (0.69) | SRCYES1FGRPIK3CDFYN | |
| SCHEMBL4823820 | 0.81 | SRC (0.44) | SRCYES1FGRPIK3CDFYN | |
| SCHEMBL18258367 | 0.81 | ABL1 (0.49) | SRCYES1FGRPIK3CDFYN | |
| SCHEMBL25033277 | 0.81 | SRC (0.47) | SRCYES1FGRPIK3CDFYN | |
| SCHEMBL4572201 | 0.80 | RET (0.48) | SRCYES1FGRPIK3CDFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10294227-B2 | Compounds | UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2019-05-21 | — | — | US | disclosed |
| US-20180127422-A1 | COMPOUNDS | UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2018-05-10 | — | — | US | disclosed |
| WO-2016185160-A1 | COMPOUNDS | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2016-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127422-A1 | COMPOUNDS | CBR3, OR10J3, CBR1 | SRC 3282/4885YES1 2234/4885FGR 1356/4885 |
| US-10294227-B2 | Compounds | CBR3, OR10J3, CBR1 | SRC 2785/4885YES1 1792/4885FGR 890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.